The federal Project Grant award R01DA058041, totaling $1,427,238, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a 5-year prospective mixed-methods investigation at Brown University to characterize cannabis use trajectories among young adults (ages 18-25). The project aims to leverage a behavioral economics framework to understand how micro-transitions and critical life events during young...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,630,395 to The Johns Hopkins University to conduct laboratory studies investigating the impact of acute delta-9-tetrahydrocannabinol (THC) administration on the motivational, subjective, and physiological effects of combustible cigarettes and electronic cigarettes. The studies will use standardized nicotine products to determine how THC...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $163,568 to Brown University to conduct a study examining the relationship between cannabis use, trauma, and cognitive decision-making processes in emerging adults. The project will recruit 70 participants from an ongoing parent study to investigate how traumatic stress reactivity, reward motivation, and inhibitory control relate to...
This Project Grant award from the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to develop a novel intervention to reduce co-use of tobacco and cannabis among pregnant and postpartum individuals, particularly those from minoritized groups.
The key objectives are to: 1) conduct formative research on the experiences of marginalized pregnant people who use cannabis and tobacco, 2) co-create an...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $645,039 to the Medical University of South Carolina (MUSC) and the University of Vermont (UVM) to conduct a 5-year naturalistic cohort study on the use patterns and trajectories of dual combustible and electronic cigarette users compared to exclusive users. The study aims to 1) describe and 2) compare the consistency of use behaviors over time, and 3)...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Medical University of South Carolina (MUSC) provides $602,786 over a 5-year period beginning June 1, 2024 to conduct a randomized controlled trial. The trial will evaluate the efficacy of the smoking cessation medication varenicline, paired with a psychosocial intervention, in treating the co-use of tobacco and cannabis among 200 adult participants in South Carolina....
This $282,298 Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research on the impact of social-contextual stressors on smoking cessation and relapse among socioeconomically disadvantaged young adults (SDYA) who smoke cigarettes. The award, granted to Brown University, aims to provide empirical evidence on the social-contextual predictors of smoking cessation in this high-risk population. The research approach...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $1,218,738 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Oklahoma Health Sciences Center. This 3-year grant, running from August 1, 2024 to March 21, 2025, will fund research to elucidate the impact of minority stress factors on tobacco use among sexual minority young adults (SMYAs), particularly those living in rural areas.
The research plan includes a 2-year longitudinal survey...
This federal Project Grant award, totaling $1,336,946, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund research at the University of California, Los Angeles (UCLA) to investigate the role of the habenula brain circuit in cigarette smoking and tobacco use disorder (TUD).
The key objectives of the project are to: 1) examine habenula functional connectivity with the salience network and ventral...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $686,376 to study the effects of medical cannabis use on physical and mental health outcomes in medical cannabis patients. The key objectives of the 5-year project are to: 1) examine the association between cannabis tolerance, specific cannabis effects, and the likelihood of developing a pathological pattern of cannabis use; 2) determine...